Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1.69 Billion by 2027, exhibiting a CAGR of 7.81% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.
Oncology Based In-Vivo CRO Market Trends:
The growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology based in-vivo CRO market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on indication, model and application.
Breakup by Indication:
Blood Cancer
Solid Tumors
Others
Breakup by Model:
Syngeneic
Xenograft
Patient Derived Xenograft (PDX)
Others
Breakup by Application:
Hospitals
Rehabilitation Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.
Key Questions Answered in This Report:
How has the global oncology based in-vivo CRO market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global oncology based in-vivo CRO market?
What are the key regional markets?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the model?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global oncology based in-vivo CRO market and who are the key players?
What is the degree of competition in the industry?
Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.
Oncology Based In-Vivo CRO Market Trends:
The growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology based in-vivo CRO market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on indication, model and application.
Breakup by Indication:
Blood Cancer
Solid Tumors
Others
Breakup by Model:
Syngeneic
Xenograft
Patient Derived Xenograft (PDX)
Others
Breakup by Application:
Hospitals
Rehabilitation Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.
Key Questions Answered in This Report:
How has the global oncology based in-vivo CRO market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global oncology based in-vivo CRO market?
What are the key regional markets?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the model?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global oncology based in-vivo CRO market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ONCOLOGY BASED IN-VIVO CRO MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY INDICATION
6.1 Blood Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Solid Tumors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY MODEL
7.1 Syngeneic
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Xenograft
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Patient Derived Xenograft (PDX)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Rehabilitation Centers
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Champions Oncology Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Charles River Laboratories International Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Crown Bioscience Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Eurofins Scientific
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Evotec SE
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 ICON Plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Labcorp Drug Development (Laboratory Corporation of America Holdings)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Living Tumor Laboratory
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Taconic Biosciences Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 The Jackson Laboratory
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 WuXi AppTec
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 Xentech
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ONCOLOGY BASED IN-VIVO CRO MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY INDICATION
6.1 Blood Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Solid Tumors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY MODEL
7.1 Syngeneic
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Xenograft
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Patient Derived Xenograft (PDX)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Rehabilitation Centers
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Champions Oncology Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Charles River Laboratories International Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Crown Bioscience Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Eurofins Scientific
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Evotec SE
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 ICON Plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Labcorp Drug Development (Laboratory Corporation of America Holdings)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Living Tumor Laboratory
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Taconic Biosciences Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 The Jackson Laboratory
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 WuXi AppTec
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 Xentech
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
LIST OF TABLES
Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million US$), 2022-2027
Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players
Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million US$), 2022-2027
Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players
LIST OF FIGURES
Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2021
Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2021
Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2021
Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2021
Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2021
Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis
Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2021
Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2021
Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2021
Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2021
Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2021
Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis
